The transforming growth factor-beta 1 (TGFβ1) promotes fibrosis, differentiating epithelial cells and quiescent fibroblasts into myofibroblasts and increasing expression of extracellular matrix. Recent investigations have shown that PPAR (peroxisome proliferator-activated receptor*) is a negative regulator of fibrotic events induced by TGFβ1. Dehydroepiandrosterone (DHEA) is an immunomodulatory hormone essential for PPAR functions, and is reduced in some processes characterized by fibrosis. Although scarring alopecia characteristically develops in the female biological period in which occurs decreased production of DHEA, there are no data in the literature relating its reduction to fibrogenic process of this condition. This article aims to review the fibrogenic activity of TGFβ1, its control by PPAR and its relation with DHEA in the frontal fibrosing alopecia.
INTRODUCTION
The frontal fibrosing alopecia (FFA) is a form of alopecia manifested in women, very rarely in men, and it begins in frontal hairline, progressing in the lateral and posterior direction, with permanent loss of hair follicles and may reach also the eyebrows and other areas. 1 Of unknown etiology and treatment with unsatisfactory results, it was recently compared to a similar type of hair loss found in mutant animals presenting changes in functions of specific intranuclear receptors.
The occurrence of this event almost exclusively in women, and those in the pre or post-adrenopause period, raises the need to relate the hormonal changes concerning the development of alopecia.
Even maintaining the present article under "review article" designation, only the essential facts to the current conceptualization of the disease are presented, leaving more space for the aspects that are considered relevant: a) Is the reduction of the local activity of dehydroepiandrosterone (DHEA) responsible for fibrosis and loss of hair follicles? b) May DHEA for topical use be useful in its treatment?
HISTORY
In 1994, Steven Kossard described a new and peculiar hair loss called the frontal fibrosing alopecia of women (FFA). 1 Its histology was similar to lichen planopilaris (LPP), without the occurrence of signs of lichen planus in the rest of the tegument.
Sixteen years before Josefowicz identified a mutant species of mouse, named Asebia, with alopecia and atrophy of sebaceous glands. 2 Genetic aspects related to alopecia in these mice were mapped in a second mutant animal, the Asebia 2, spontaneously developed in laboratory and with extreme atrophy of sebaceous glands and hair follicles progressing to fibrosis. 3 The genotype of these animals, with changes resulting from chromosome 11 mutations, was identified, evidencing the entire follicular degeneration process. 4 The fact that the activity of PPAR α and γ was essential for the differentiation and functions of sebocytes was followed by identification of malfunctions of these receptors in Asebia 2.
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It has been shown that deletion of PPARγ in the follicular bulge generated changes similar to LPP. 6 Similarly, the finding that the functional maintenance of hair follicles depends on the presence of multipotent cells in the bulge demonstrated the importance of investigating the effect of stimulant drugs of PPARs in the treatment of alopecia. 7 The fibrosing inflammatory follicular changes in Asebias were reviewed and appraised as not autoimmune. Stem cell markers aberrations in the follicles during the cell cycle were demonstrated and accountable for the changes presented. 8 PPARγ. 5 Mice depleted of the gene of this receptor lose the stem cells of the bulges and develop fibrosing alopecia. 5, 6 PPARγ is indispensable for the maintenance of stem cells of functional epithelium in hair follicles. 5 Deletion of the PPARγ gene in the bulge area of the hair resulted in a skin process is similar to LPP alopecia. 6 The location of the inflammatory infiltrate is typically centered on the bulge region. 
38
TGFβ1 is a pro-oncogenic cytokine that leads to epithelial/ mesenchymal transdifferentiation and to fibroblast/myofibroblast transition, a crucial event for collagen synthesis. [39] [40] [41] [42] The development of fibrosis after tissue injury requires activation of TGFβ1. 42 Currently, it is accepted that the epithelial/mesenchymal transition, primarily described in critical stages of embryogenesis, may occur both in development of tumors and in non-tumor tissues, by the action of TGFβ1, together with different local growth factors. 41 This transition, concomitant with increased TGFβ1, is carried out via SMAD protein, transducer of the extracellular signal, increasing the production of reactive oxygen species (ROS) in the cytoplasm and mitochondria. 42, 43 These facts have led researchers to experiment with dif- years, with only 10% to 20% of peak levels. 47 DHEA performs immunomodulatory role and is essential for the nuclear receptor PPAR in the transcription of genes, in fat metabolism, and in mitochondrial activity. [48] [49] The imbalance of its functions can trigger inflammatory and autoimmune changes. 48 DHEA is synthesized in several somatic sites, such as adrenal cortex, ovarian theca and brain. Skin cells have all the biochemical structure necessary for the production of glucocorticoid, estrogen and androgens. This synthesis can be performed from systemic origin precursors or, alternatively, through conversion of cholesterol to pregnenolone and its subsequent transformation to biologically active steroids. 50 Disorders in cutaneous steroidogenesis may have local and systemic effects, triggering inflammatory or autoimmune processes. 50 Cutaneous steroidogenesis, which mainly occurs in the sebaceous gland, has a distinct pattern of evolutionary topographic behavior during the aging process, as evidenced by studies conducted only in males. DHEA and androstenedione concentrations measured in the liquid content of suction blisters in different areas of the body were compared to the blood level in young men (27, 8 years) and elderly subjects (62.6 years). Increased concentration of DHEA was found, and not of androstenedione, in the liquid of the blisters of the elderly subjects, inversely to reduced blood levels. In the studied skin sites, the differences between young and old individuals were higher. 51 Similar tissue studies in women have not been found in the literature.
The importance of the effect of DHEA on mitochondrial oxidative metabolism was stabilished by administration of this hormone in rats. These animals showed increased liver and brain metabolism with elevated brain weight without concurrent increase in body weight. 52 The results observed in the topographic response is demonstrative of the variation in distribution of DHEA receptors in the body of these animals.
Tests with radioactive DHEA administered to dogs confirmed their higher metabolism in fibroblasts derived from dermal follicles and, among these, in dermal fibroblasts derived from the follicles of the skulls of the animals, accentuating the topographic differences of their receptors. 53 The relation between the activity of DHEA and FFA is also suggested by the reduction of DHEA levels in different conditions characterized by fibrosis, such as occurs in idiopathic pulmonary fibrosis. 47 A comparison of the serum levels of DHEA/DHEAS of 137 patients with idiopathic pulmonary fibrosis and 58 controls showed a significant reduction of these hormones in patients, both in plasma and in the bronchoalveolar lavage fluid.
The importance of DHEA in the fibrogenic process was also demonstrated by the addition of DHEA to cultured fibroblasts obtained from bronchoalveolar lavage from patients, which resulted in the lowest differentiation in myofibroblasts and decrease in collagen production and duplication of apoptosis levels compared to cultivated ones without the addition of hormone. 47 Idiopathic fibrosis is a disease related to aging and is characterized by expansion of myofibroblasts and lung remodeling. 
DISCUSSION
The exposed aspects that relate to fibrogenic activity to reduction of PPARs function and their dependence of the activation by DHEA, lead us to suppose that the reduced activity of this hormone, characteristic of the phase in which this alopecia occurs, correlates directly to fibrogenic inflammatory process of FFA.
Knowing that the activity of a hormone depends on both its blood content as the functional integrity of specific cellular receptors, and that these are presented in topographic and individual 
